Ramesh Jayaraman

1.2k total citations
18 papers, 898 citations indexed

About

Ramesh Jayaraman is a scholar working on Oncology, Molecular Biology and Genetics. According to data from OpenAlex, Ramesh Jayaraman has authored 18 papers receiving a total of 898 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 6 papers in Molecular Biology and 6 papers in Genetics. Recurrent topics in Ramesh Jayaraman's work include Cytokine Signaling Pathways and Interactions (7 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Ramesh Jayaraman is often cited by papers focused on Cytokine Signaling Pathways and Interactions (7 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Ramesh Jayaraman collaborates with scholars based in Singapore, India and United States. Ramesh Jayaraman's co-authors include Kantharaj Ethirajulu, Stefan Hart, Anthony D. William, Brian Dymock, Jeanette M. Wood, Veronica Novotny‐Diermayr, Anders Poulsen, Kee Chuan Goh, Eric T. Sun and Hannes Hentze and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Immunology and Scientific Reports.

In The Last Decade

Ramesh Jayaraman

17 papers receiving 876 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ramesh Jayaraman Singapore 15 433 352 344 253 143 18 898
Zi-Jie Long China 23 797 1.8× 387 1.1× 100 0.3× 225 0.9× 71 0.5× 29 1.4k
Raji Sundaramoorthi United States 15 468 1.1× 208 0.6× 179 0.5× 263 1.0× 33 0.2× 23 869
Ruriko Tanaka Japan 14 357 0.8× 159 0.5× 199 0.6× 346 1.4× 44 0.3× 23 727
Jennifer M. Golas United States 14 405 0.9× 192 0.5× 215 0.6× 315 1.2× 39 0.3× 24 893
Valérie Lagarde France 14 414 1.0× 254 0.7× 508 1.5× 710 2.8× 59 0.4× 27 1.2k
Michelle L. Kraus United States 7 466 1.1× 447 1.3× 68 0.2× 145 0.6× 30 0.2× 9 1.1k
Michele S. Redell United States 18 562 1.3× 402 1.1× 117 0.3× 315 1.2× 100 0.7× 50 1.1k
Paweł Robak Poland 19 539 1.2× 372 1.1× 343 1.0× 410 1.6× 269 1.9× 86 1.1k
Tea Pemovska Finland 12 392 0.9× 143 0.4× 138 0.4× 254 1.0× 33 0.2× 25 751
Eloisi Caldas-Lopes United States 7 482 1.1× 152 0.4× 106 0.3× 84 0.3× 52 0.4× 11 737

Countries citing papers authored by Ramesh Jayaraman

Since Specialization
Citations

This map shows the geographic impact of Ramesh Jayaraman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ramesh Jayaraman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ramesh Jayaraman more than expected).

Fields of papers citing papers by Ramesh Jayaraman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ramesh Jayaraman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ramesh Jayaraman. The network helps show where Ramesh Jayaraman may publish in the future.

Co-authorship network of co-authors of Ramesh Jayaraman

This figure shows the co-authorship network connecting the top 25 collaborators of Ramesh Jayaraman. A scholar is included among the top collaborators of Ramesh Jayaraman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ramesh Jayaraman. Ramesh Jayaraman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Nanjundappa, Mahesh, et al.. (2023). Neutropenic Rat Thigh Infection Model for Evaluation of the Pharmacokinetics/Pharmacodynamics of Anti-Infectives. Microbiology Spectrum. 11(4). e0013323–e0013323. 2 indexed citations
2.
Jayaraman, Ramesh, et al.. (2021). Effect of Blood Pressure Reduction on Intraocular Pressure and Ophthalmic Artery Blood Flow Velocity in Hypertension. Journal of Ocular Pharmacology and Therapeutics. 38(2). 148–155.
3.
Nanjundappa, Mahesh, et al.. (2020). Pharmacokinetics/Pharmacodynamics (PK/PD) of Ciprofloxacin in the Complicated Urinary Tract Infection (cUTI) Model in Diabetic Mice. Current Drug Metabolism. 21(2). 132–139. 2 indexed citations
4.
Kulkarni, Aditya, Paola Caporali, Sandeep Goyal, et al.. (2018). Linear Cyclodextrin Polymer Prodrugs as Novel Therapeutics for Niemann-Pick Type C1 Disorder. Scientific Reports. 8(1). 9547–9547. 27 indexed citations
5.
P, Shahul Hameed, Nagakumar Bharatham, Sreevalli Sharma, et al.. (2018). Nitrothiophene carboxamides, a novel narrow spectrum antibacterial series: Mechanism of action and Efficacy. Scientific Reports. 8(1). 7263–7263. 20 indexed citations
6.
Jayaraman, Ramesh, Mohammed Khysar Pasha, Anthony P. Williams, Kee Chuan Goh, & Kantharaj Ethirajulu. (2015). Metabolism and Disposition of Pacritinib (SB1518), an Orally Active Janus Kinase 2 Inhibitor in Preclinical Species and Humans. Drug Metabolism Letters. 9(1). 28–47. 14 indexed citations
7.
Novotny‐Diermayr, Veronica, Stefan Hart, Albert Cheong, et al.. (2012). The oral HDAC inhibitor pracinostat (SB939) is efficacious and synergistic with the JAK2 inhibitor pacritinib (SB1518) in preclinical models of AML. Blood Cancer Journal. 2(5). e69–e69. 87 indexed citations
8.
Madan, Babita, Kee Chuan Goh, Stefan Hart, et al.. (2012). SB1578, a Novel Inhibitor of JAK2, FLT3, and c-Fms for the Treatment of Rheumatoid Arthritis. The Journal of Immunology. 189(8). 4123–4134. 27 indexed citations
9.
Younes, Anas, Jorge Romaguera, Michelle A. Fanale, et al.. (2012). Phase I Study of a Novel Oral Janus Kinase 2 Inhibitor, SB1518, in Patients With Relapsed Lymphoma: Evidence of Clinical and Biologic Activity in Multiple Lymphoma Subtypes. Journal of Clinical Oncology. 30(33). 4161–4167. 119 indexed citations
10.
Pasha, Mohammad, Ramesh Jayaraman, Venkatesh Pilla Reddy, et al.. (2012). Preclinical Metabolism and Pharmacokinetics of SB1317 (TG02), a Potent CDK/JAK2/FLT3 Inhibitor. Drug Metabolism Letters. 6(1). 33–42. 17 indexed citations
11.
12.
Novotny‐Diermayr, Veronica, Nina Sausgruber, Yung Kiang Loh, et al.. (2011). Pharmacodynamic Evaluation of the Target Efficacy of SB939, an Oral HDAC Inhibitor with Selectivity for Tumor Tissue. Molecular Cancer Therapeutics. 10(7). 1207–1217. 19 indexed citations
13.
Novotny‐Diermayr, Veronica, Stefan Hart, Yung Kiang Loh, et al.. (2011). TG02, a novel oral multi-kinase inhibitor of CDKs, JAK2 and FLT3 with potent anti-leukemic properties. Leukemia. 26(2). 236–243. 105 indexed citations
14.
Hart, Stefan, Veronica Novotny‐Diermayr, Hannes Hentze, et al.. (2011). SB1518, a novel macrocyclic pyrimidine-based JAK2 inhibitor for the treatment of myeloid and lymphoid malignancies. Leukemia. 25(11). 1751–1759. 152 indexed citations
15.
Jayaraman, Ramesh, Venkatesh Pilla Reddy, Mohammad Pasha, et al.. (2011). Preclinical Metabolism and Disposition of SB939 (Pracinostat), an Orally Active Histone Deacetylase Inhibitor, and Prediction of Human Pharmacokinetics. Drug Metabolism and Disposition. 39(12). 2219–2232. 17 indexed citations
16.
17.
18.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zi-Jie Long Breakdown of academic impact, for papers by Raji Sundaramoorthi Breakdown of academic impact, for papers by Ruriko Tanaka Breakdown of academic impact, for papers by Jennifer M. Golas Breakdown of academic impact, for papers by Valérie Lagarde Breakdown of academic impact, for papers by Michelle L. Kraus Breakdown of academic impact, for papers by Michele S. Redell Breakdown of academic impact, for papers by Paweł Robak Breakdown of academic impact, for papers by Tea Pemovska Breakdown of academic impact, for papers by Eloisi Caldas-Lopes
Rankless by CCL
2026